Cipla

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE059A01026
  • NSEID: CIPLA
  • BSEID: 500087
INR
1,324.00
12.25 (0.93%)
BSENSE

Feb 03

BSE+NSE Vol: 28.28 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Lupin
Torrent Pharma
Sun Pharma.Inds.
Aurobindo Pharma
Alkem Lab
Biocon
Divi's Lab.
Dr Reddy's Labs
Zydus Lifesci.
Cipla
Mankind Pharma
Why is Cipla Ltd. ?
1
Company has a low Debt to Equity ratio (avg) at 0 times
2
Healthy long term growth as Operating profit has grown by an annual rate 19.77%
3
Flat results in Sep 25
  • CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 795.85 cr
  • DEBTORS TURNOVER RATIO(HY) Lowest at 4.03 times
4
With ROE of 16.5, it has a Attractive valuation with a 3.7 Price to Book Value
  • The stock is trading at a fair value compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 1.01%, its profits have risen by 17.9% ; the PEG ratio of the company is 1.3
5
High Institutional Holdings at 54.8%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Cipla for you?

Low Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Cipla
-7.2%
0.05
20.17%
Sensex
8.49%
0.44
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
8.41%
EBIT Growth (5y)
12.47%
EBIT to Interest (avg)
60.10
Debt to EBITDA (avg)
0.19
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.94
Tax Ratio
24.52%
Dividend Payout Ratio
24.51%
Pledged Shares
0
Institutional Holding
54.66%
ROCE (avg)
21.71%
ROE (avg)
14.59%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
22
Industry P/E
32
Price to Book Value
3.22
EV to EBIT
18.43
EV to EBITDA
15.19
EV to Capital Employed
3.92
EV to Sales
3.46
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
24.20%
ROE (Latest)
16.53%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
NO KEY POSITIVE TRIGGERS
-15What is not working for the Company
PAT(Q)

At Rs 884.19 cr has Fallen at -35.0% (vs previous 4Q average

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 795.85 cr

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.03 times

PBDIT(Q)

Lowest at Rs 1,255.06 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at 17.74%

PBT LESS OI(Q)

Lowest at Rs 962.68 cr.

EPS(Q)

Lowest at Rs 8.37

Loading Valuation Snapshot...
Here's what is not working for Cipla
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 962.68 cr has Fallen at -35.9% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 1,501.32 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 884.19 cr has Fallen at -35.0% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 1,360.29 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs 1,255.06 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at 17.74%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 962.68 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs 8.37
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 795.85 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio- Half Yearly
Lowest at 4.03 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio